Emend for Multiple-day Emetogenic Chemotherapy

NCT00711555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Nausea
Vomiting

Interventions

DRUG: aprepitant, ondansetron, dexamethasone

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]
[object Object]